Lothar Wiese
Roskilde, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 141 publications
Electronic Nudges to Increase Influenza Vaccination Uptake in Young and Middle-Aged Patients with Heart Failure: A Prespecified Analysis of the NUDGE-FLU-CHRONIC Trial.
Journal: Circulation. Heart failure
Published: August 29, 2026
Bivalent RSV Prefusion F Vaccine to Prevent Hospitalizations in Adults.
Journal: NEJM evidence
Published: August 29, 2026
Durability of RSV Prefusion F Vaccine Protection across Two RSV Seasons.
Journal: NEJM evidence
Published: August 29, 2026
RSV vaccine for preventing respiratory and cardiovascular hospitalizations in heart failure: a prespecified analysis of the extended DAN-RSV trial.
Journal: European journal of heart failure
Published: August 08, 2026
Effectiveness of Bivalent RSV Prefusion F Protein-based Vaccine in Individuals With and Without Atrial Fibrillation: A Prespecified Analysis of the DAN-RSV Trial.
Journal: Journal of the American College of Cardiology
Published: August 02, 2026
Effectiveness of High-Dose versus Standard-Dose Influenza Vaccine against Venous Thromboembolic Events: A Post Hoc Analysis of the DANFLU-2 Trial.
Journal: European journal of preventive cardiology
Published: July 31, 2026
Risk of Myocarditis and Pericarditis With Bivalent RSV Prefusion F Protein-Based Vaccine: A Safety Analysis of the Extended DAN-RSV Trial.
Journal: Journal of the American College of Cardiology
Published: July 26, 2026
High-dose vs. standard-dose influenza vaccine in heart failure: the FLUNITY-HD trial.
Journal: European heart journal
Published: July 07, 2026
Borrelia or Bell's? Development of BoB: a clinical decision support tool to differentiate Lyme neuroborreliosis facial palsy from Bell's palsy.
Journal: Ticks and tick-borne diseases
Published: June 01, 2026
A Pragmatic Randomized Trial to Evaluate the Vaccine Effectiveness of Bivalent RSV prefusion F Vaccine for Preventing RSV Hospitalizations in Adults (DAN-RSV): Trial Design Update.
Journal: American heart journal
Published: May 25, 2026
A pragmatic randomized trial to evaluate the vaccine effectiveness of bivalent RSV prefusion F vaccine for preventing RSV hospitalizations in adults (DAN-RSV): Trial design update.
Journal: American heart journal
Published: May 25, 2026
Bivalent RSV Prefusion F Protein-Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial.
Journal: Diabetes care
Published: March 05, 2026
Last Updated: 09/26/2026